- Report
- August 2023
- 75 Pages
North America
From €4579EUR$4,750USD£3,917GBP
- Report
- February 2024
- 100 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1205EUR$1,250USD£1,031GBP
- Report
- February 2024
- 90 Pages
Middle East, Africa
From €4579EUR$4,750USD£3,917GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4579EUR$4,750USD£3,917GBP
- Report
- March 2024
- 194 Pages
Global
From €3253EUR$3,374USD£2,782GBP
€3614EUR$3,749USD£3,091GBP
- Report
- July 2023
- 220 Pages
Global
From €1919EUR$1,990USD£1,641GBP
- Report
- March 2024
- 134 Pages
Global
From €5736EUR$5,950USD£4,906GBP
- Report
- May 2024
- 196 Pages
Global
From €4772EUR$4,950USD£4,081GBP
- Report
- May 2024
- 262 Pages
Global
From €5254EUR$5,450USD£4,494GBP
- Report
- February 2024
- 150 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- April 2024
- 30 Pages
Global
From €3133EUR$3,250USD£2,680GBP
- Report
- April 2024
- 30 Pages
Global
From €3133EUR$3,250USD£2,680GBP
- Report
- February 2024
- 30 Pages
Global
From €3133EUR$3,250USD£2,680GBP
- Report
- October 2023
- 177 Pages
Global
From €4724EUR$4,900USD£4,040GBP
From €6267EUR$6,500USD£5,360GBP
- Report
- February 2024
- 150 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Drug Pipelines
- April 2024
- 100 Pages
Global
From €2892EUR$3,000USD£2,474GBP
- Clinical Trials
- April 2024
- 200 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1205EUR$1,250USD£1,031GBP
The Sodium Dependent Glucose Co Transporter 2 (SGLT2) market is a subset of the Endocrine and Metabolic Disorders Drugs market. SGLT2 inhibitors are a class of drugs used to treat type 2 diabetes, a chronic condition in which the body does not produce enough insulin or is unable to use insulin effectively. These drugs work by blocking the reabsorption of glucose in the kidneys, allowing it to be excreted in the urine. This helps to reduce blood glucose levels and improve glycemic control.
The SGLT2 market is highly competitive, with several major pharmaceutical companies offering products. These include AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen Pharmaceuticals, Merck, Novo Nordisk, and Sanofi. Each company offers a range of products, including both branded and generic versions. Show Less Read more